Detalhe da pesquisa
1.
Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults.
BMC Infect Dis
; 18(1): 186, 2018 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669531
2.
Vaccine for prevention of mild and moderate-to-severe influenza in children.
N Engl J Med
; 369(26): 2481-91, 2013 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24328444
3.
A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine.
BMC Infect Dis
; 14: 133, 2014 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24606983
4.
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.
J Infect Dis
; 208(4): 544-53, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23847058
5.
Vaccine for prevention of influenza in children.
N Engl J Med
; 370(12): 1167-8, 2014 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24645953
6.
Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults.
Hum Vaccin
; 7(1): 81-8, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21285532
7.
Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial.
Pediatr Infect Dis J
; 39(1): e1-e10, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31725115
8.
Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
Vaccine
; 37(35): 4823-4829, 2019 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362819
9.
Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations.
Vaccine
; 37(35): 4830-4834, 2019 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362820
10.
Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children.
Pediatr Infect Dis J
; 38(2): 203-210, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30325891
11.
Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine.
Pediatr Infect Dis J
; 38(8): 866-872, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306399
12.
Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons.
Lancet Child Adolesc Health
; 2(5): 338-349, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30169267
13.
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-inferiority trial.
Vaccine
; 35(46): 6321-6328, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28987445
14.
Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil.
Braz J Infect Dis
; 21(1): 63-70, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27912069
15.
Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial.
J Pediatric Infect Dis Soc
; 6(1): 9-19, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28062552
16.
Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial.
J Pediatric Infect Dis Soc
; 5(2): 170-9, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407273
17.
Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
Expert Rev Vaccines
; 15(2): 201-14, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26641539
18.
Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial.
J Pediatric Infect Dis Soc
; 4(3): 242-51, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26336604
19.
Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age.
Pediatr Infect Dis J
; 33(12): 1262-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25386965
20.
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.
Vaccine
; 32(13): 1480-7, 2014 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24486352